HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomized trial of intracervical prostaglandin gel and intravenous oxytocin in prelabor rupture of membranes with unripe cervix at term.

Abstract
In order to compare the efficacy of immediate intravenous oxytocin administration and intracervical prostaglandin E2 gel application in premature rupture of membranes with unfavorable cervices at term, 45 term pregnant patients with premature rupture of membranes were randomized into two groups. Twenty women received immediate intravenous oxytocin after cleansing enema while the rest were treated with intracervical prostaglandin E2 gel. Means of maternal age, gestational age, Bishop score at admission and the rates of nulliparity did not show any significant differences between the two groups (p > 0.05). The mean rupture to delivery time was 12.6 +/- 4.4 hours in the oxytocin group and 16.5 +/- 4.5 hours in the prostaglandin group (p < 0.01). Mean birth weights and Apgar scores were insignificant. Cesarean section rates were 24% in the oxytocin group and 5% in the other (p < 0.05). No infectious morbidity was seen in any case. In conclusion, although delivery is delayed with the intracervical prostaglandin approach, cesarean section rate is lowered without an increase in infectious morbidity.
AuthorsT Bilgin, M Kadioğlu, V Yildirim, C Cengiz
JournalClinical and experimental obstetrics & gynecology (Clin Exp Obstet Gynecol) Vol. 25 Issue 1-2 Pg. 46-8 ( 1998) ISSN: 0390-6663 [Print] Singapore
PMID9743881 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Gels
  • Oxytocics
  • Oxytocin
  • Dinoprostone
Topics
  • Administration, Topical
  • Adult
  • Dinoprostone (administration & dosage, therapeutic use)
  • Female
  • Fetal Membranes, Premature Rupture (therapy)
  • Gels
  • Humans
  • Injections, Intravenous
  • Oxytocics (administration & dosage, therapeutic use)
  • Oxytocin (administration & dosage, therapeutic use)
  • Pregnancy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: